Bridgeway Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bridgeway Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,075	Closed	-$244K	–	1495
2016 Q2	$244K	Hold	3,075	–	–	﹤0.01%	1266
2016 Q1	$234K	Hold	3,075	–	–	﹤0.01%	1274
2015 Q4	$276K	Hold	3,075	–	–	0.01%	1222
2015 Q3	$344K	Hold	3,075	–	–	0.01%	1176
2015 Q2	$313K	Hold	3,075	–	–	0.01%	1239
2015 Q1	$336K	Buy	+3,075	New	+$315K	0.01%	1225

Other funds holding PLXP

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bridgeway Capital Management's PLXP Position: Q3 2016 in Review

Bridgeway Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2016, closing a stake of 3,075 shares — an estimated $244K sold.

Bridgeway Capital Management first reported a position in PLXP in Q1 2015 and held it in 6 quarters. The position peaked at $344K in Q3 2015. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

Bridgeway Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Bridgeway Capital Management sold 3,075 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $244K.
Bridgeway Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2015 and held it in 6 quarters.
Bridgeway Capital Management's PLx Pharma Inc. Common Stock position peaked at $344K in Q3 2015.
32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Bridgeway Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.